Tower Research Capital LLC (TRC)

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1533421 NEW YORK, NY

Position in OBIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,324

-$356 QoQ

Shares Held

547

-15.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $67,724,931 across 440 Biotechnology names. OBIO ranks #380 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	12,112	$8,844,787
2	VRTX	Vertex Pharmaceuticals Inc / Ma	13,904	$6,208,692
3	REGN	Regeneron Pharmaceuticals, Inc.	4,378	$3,382,617
4	ALNY	Alnylam Pharmaceuticals, Inc.	9,627	$3,185,285
5	INSM	INSMED Inc	15,410	$2,519,843
6	LKFT	Lakefront Biotherapeutics NV	66,536	$1,996,080
7	MRNA	Moderna, Inc.	33,728	$1,713,382
8	BBIO	BridgeBio Pharma, Inc.	14,349	$1,065,556

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,324	547	-15.3%	Shares	Defined	2026-05-15
2025-12-31	$2,680	646	-97.7%	Shares	Defined	2026-02-17
2025-06-30	$74,830	27,922	+1137.7%	Shares	Defined	2025-08-15
2025-03-31	$9,655	2,256	-2.9%	Shares	Defined	2025-05-15
2024-12-31	$9,292	2,323	+21.2%	Shares	Defined	2025-02-13
2024-09-30	$9,848	1,916	-60.8%	Shares	Defined	2024-11-14
2024-06-30	$39,812	4,885	+185.5%	Shares	Defined	2024-08-13
2024-03-31	$9,016	1,711	-30.7%	Shares	Defined	2024-05-15
2023-12-31	$22,532	2,468	+58.5%	Shares	Defined	2024-02-13
2023-09-30	$13,576	1,557	+185.7%	Shares	Defined	2023-11-14
2023-06-30	$3,815	545	-40.0%	Shares	Defined	2023-08-14
2023-03-31	$17,769	908	—	Shares	Defined	2023-05-09
No filing history on record for this holder in this stock.